BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Treatment
30 results:

  • 1. A cross-sectional study of the prevalence, barriers, and facilitators of cervical cancer screening in family planning clinics in Mombasa County, Kenya.
    Eastment MC; Wanje G; Richardson BA; Mwaringa E; Patta S; Sherr K; Barnabas RV; Mandaliya K; Jaoko W; McClelland RS
    BMC Health Serv Res; 2022 Dec; 22(1):1577. PubMed ID: 36564740
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessing community health workers' time allocation for a cervical cancer screening and treatment intervention in Malawi: a time and motion study.
    Chinkhumba J; Low D; Ziphondo E; Msowoya L; Rao D; Smith JS; Schouten E; Mwapasa V; Gadama L; Barnabas R; Chinula L; Tang JH
    BMC Health Serv Res; 2022 Sep; 22(1):1196. PubMed ID: 36151553
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Fertility preservation techniques in cervical carcinoma.
    Silvestris E; Paradiso AV; Minoia C; Daniele A; Cormio G; Tinelli R; D'Oronzo S; Cafforio P; Loizzi V; Dellino M
    Medicine (Baltimore); 2022 Apr; 101(17):e29163. PubMed ID: 35512072
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Fertility-sparing surgery and fertility preservation in cervical cancer: The desire for parenthood, reproductive and obstetric outcomes.
    van der Plas RCJ; Bos AME; Jürgenliemk-Schulz IM; Gerestein CG; Zweemer RP
    Gynecol Oncol; 2021 Dec; 163(3):538-544. PubMed ID: 34583837
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Fertility preservation in cervical cancer, analysis of 30 years of practice and immersion in future developments].
    Bréban-Kehl M; Zaccarini F; Sanson C; Maulard A; Scherier S; Genestie C; Chargari C; Pautier P; Leary A; Balleyguier C; Morice P; Gouy S
    Gynecol Obstet Fertil Senol; 2022 Jan; 50(1):62-68. PubMed ID: 34487915
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Ovarian transposition and cervical cancer.
    Laios A; Duarte Portela S; Papadopoulou A; Gallos ID; Otify M; Ind T
    Best Pract Res Clin Obstet Gynaecol; 2021 Sep; 75():37-53. PubMed ID: 33715965
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A survey of French gynecologists' knowledge and attitudes toward conservative treatment for fertility preservation in young patients with endometrial cancer.
    Peigné M; Maumy L; Koskas M
    J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101794. PubMed ID: 32416273
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ovarian Stimulation Is Safe and Effective for Patients with Gynecologic cancer.
    Akel RA; Guo XM; Moravek MB; Confino R; Smith KN; Lawson AK; Klock SC; Tanner Iii EJ; Pavone ME
    J Adolesc Young Adult Oncol; 2020 Jun; 9(3):367-374. PubMed ID: 31923372
    [No Abstract]    [Full Text] [Related]  

  • 9. The Diagnostic Accuracy and Postoperative Outcomes of Cervical cancer Patients for MR-invisible or MR-visible Diagnosis of Combined T2- and Diffusion-weighted 3T MRI Using the External Phased-array Receiver.
    Roh HJ; Go EB; Kim KB; Lee JH; Lee SH
    Anticancer Res; 2019 Dec; 39(12):6945-6956. PubMed ID: 31810966
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Familial Kidney cancer: Implications of New Syndromes and Molecular Insights.
    Carlo MI; Hakimi AA; Stewart GD; Bratslavsky G; Brugarolas J; Chen YB; Linehan WM; Maher ER; Merino MJ; Offit K; Reuter VE; Shuch B; Coleman JA
    Eur Urol; 2019 Dec; 76(6):754-764. PubMed ID: 31326218
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Para-aortic plus pelvic lymphadenectomy in locally advanced cervical cancer: A single institutional experience.
    Mezquita G; Muruzabal JC; Perez B; Aguirre S; Villafranca E; Jurado M
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():79-83. PubMed ID: 30889424
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Implementing a Fee-for-Service Cervical cancer Screening and treatment Program in Cameroon: Challenges and Opportunities.
    DeGregorio G; Manga S; Kiyang E; Manjuh F; Bradford L; Cholli P; Wamai R; Ogembo R; Sando Z; Liu Y; Sheldon LK; Nulah K; Welty T; Welty E; Ogembo JG
    Oncologist; 2017 Jul; 22(7):850-859. PubMed ID: 28536303
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant K
    Dickie BR; Rose CJ; Kershaw LE; Withey SB; Carrington BM; Davidson SE; Hutchison G; West CML
    Br J Cancer; 2017 May; 116(11):1436-1443. PubMed ID: 28449009
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer.
    Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1638-43. PubMed ID: 26177790
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16.
    Louvanto K; Franco EL; Ramanakumar AV; Vasiljević N; Scibior-Bentkowska D; Koushik A; Cuzick J; Coutlée F; Lorincz AT;
    Int J Cancer; 2015 Mar; 136(6):E638-45. PubMed ID: 25203794
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tracer kinetic model selection for dynamic contrast-enhanced magnetic resonance imaging of locally advanced cervical cancer.
    Kallehauge JF; Tanderup K; Duan C; Haack S; Pedersen EM; Lindegaard JC; Fokdal LU; Mohamed SM; Nielsen T
    Acta Oncol; 2014 Aug; 53(8):1064-72. PubMed ID: 25034348
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic significance of cyclooxygenase-2 in cervical cancer: a meta-analysis.
    Huang M; Chen Q; Xiao J; Liu C; Zhao X
    Int J Cancer; 2013 Jan; 132(2):363-73. PubMed ID: 22729746
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The soluble EP2 receptor FuEP2/Ex2 suppresses endometrial cancer cell growth in an orthotopic xenograft model in nude mice.
    Takahashi T; Ogawa H; Izumi K; Uehara H
    Cancer Lett; 2011 Jul; 306(1):67-75. PubMed ID: 21419570
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Fertility considerations in the management of gynecologic malignancies.
    Noyes N; Knopman JM; Long K; Coletta JM; Abu-Rustum NR
    Gynecol Oncol; 2011 Mar; 120(3):326-33. PubMed ID: 20943258
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.